Copyright
        ©The Author(s) 2018.
    
    
        World J Gastroenterol. Apr 14, 2018; 24(14): 1550-1561
Published online Apr 14, 2018. doi: 10.3748/wjg.v24.i14.1550
Published online Apr 14, 2018. doi: 10.3748/wjg.v24.i14.1550
		Figure 1 Study design (A) and patient disposition (B).
		
			 EE: Erosive esophagitis.
		
	
		Figure 2 Time course of serum gastrin, pepsinogen I, and pepsinogen II concentrations.
		
			 Data expressed as arithmetic mean ± SD. eP < 0.0001 for VPZ 10 mg or 20 mg vs LPZ 15 mg. LPZ: Lansoprazole; SD: Standard deviation; VPZ: Vonoprazan.
		
	
- Citation: Ashida K, Iwakiri K, Hiramatsu N, Sakurai Y, Hori T, Kudou K, Nishimura A, Umegaki E. Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole. World J Gastroenterol 2018; 24(14): 1550-1561
- URL: https://www.wjgnet.com/1007-9327/full/v24/i14/1550.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i14.1550

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                         
                         
			